What is the initial dosing of Amiodarone for Puseless Vtach?

The initial dosing of Amiodarone for pulseless ventricular tachycardia (Vtach) is 300 mg administered intravenously as a push (IVP). This high-dose administration is crucial in the advanced cardiac life support (ACLS) protocol for treating this critical condition. Amiodarone is an antiarrhythmic medication that functions by stabilizing the cardiac membrane and is particularly effective in managing life-threatening arrhythmias.

In the case of pulseless Vtach, rapid intervention is vital, and the 300 mg dose is specifically recommended due to its efficacy in restoring normal cardiac rhythms. After administering the initial dose, if necessary, a second dose of 150 mg can be given if the arrhythmia persists. This structured approach ensures that the patient receives adequate treatment in a timely manner to improve the chances of successful resuscitation and survival.

Other dosing options provided do not align with the established ACLS guidelines for pulseless Vtach, which emphasizes the importance of using the correct initial dosing for effective management in emergency situations.